Abstract
Advanced glycation end-products (AGEs) are associated with a non-enzymatic reaction between the amino group of a protein and the carbonyl group of a sugar during hyperglycemia. The precipitation of AGEs in different tissues leads to many complications, such as endothelial dysfunction, cardiovascular complications, atherosclerosis, retinopathy, neuropathy, and Alzheimer’s disease. Garcinia mangostana L. (Clusiaceae) (GM) was selected owing to the ability of its polar and non-polar fractions to inhibit AGE formation. For the first time, the bioguided fractionation of its pericarp MeOH extract (GMT) gave rise to two new xanthones, namely, mangostanaxanthones III (1) and IV (3), in addition to six known compounds, β-mangostin (2), garcinone E (4), rubraxanthone (5), α-mangostin (6), garcinone C (7), and 9-hydroxycalabaxanthone (8), from the non-polar faction. Their structures were verified by various spectroscopic methods, including 1D and 2D NMR studies and high-resolution MS data. All of the isolated xanthones significantly inhibited both sugar (ribose) and dicarbonyl compound (methylglyoxal)-induced protein glycation in a dose-dependent manner. This is explained by the ability of the isolated xanthones to inhibit protein oxidation, as indicated by the decreases in dityrosine and N′-formylkynurenine formation.
Similar content being viewed by others
References
Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18:1–14
Seidler NW (2013) Basic biology of GAPDH. Adv Exp Med Biol 985:1–36
Lv L, Shao X, Chen H, Ho C-T, Sang S (2011) Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol 24:579–586
Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47:3–27
Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ (2005) Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 28:2465–2471
Shanlin FU, Stocker R, Davies MJ (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1–18
Li L, Han A-R, Kinghorn AD, Frye RF, Derendorf H, Butterweck V (2013) Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Planta Med 79:646–653
Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML (1993) Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221–232
Sadowska-Bartosz I, Galiniak S, Bartosz G (2014) Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules 19:4880–4896
Okada Y, Okada M (2015) Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells. J Pharm Bioallied Sci 7:145
Devalaraja S, Jain S, Yadav H (2011) Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res Int 44:1856–1865
Abdallah H, El-Bassossy H, El-Halawany A, Mohamed G, Alshali K, Banjar Z (2015) PP. 14.02: Psiadia punctulata and Garcinia mangostana have potent vasorelaxant activity on isolated rat aorta. J Hypertens 33:e246
Abdallah HM, El-Bassossy H, Mohamed GA, El-Halawany AM, Alshali KZ, Banjar ZM (2016) Phenolics from Garcinia mangostana inhibit advanced glycation endproducts formation: effect on Amadori products, cross-linked structures and protein thiols. Molecules 21:251
Jia B, Li S, Hu X, Zhu G, Chen W (2015) Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi. AAPS Pharm Sci Tech 16:742–758
Morel C, Séraphin D, Oger J-M, Litaudon M, Sévenet T, Richomme P, Bruneton J (2000) New xanthones from Calophyllum caledonicum. J Nat Prod 63:1471–1474
Silverstein RM, Webster FX (1998) Spectrometric identification of organic compounds. Wiley, New York
Mohamed GA, Ibrahim SR, Shaaban MI, Ross SA (2014) Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia 98:215–221
Suksamrarn S, Suwannapoch N, Ratananukul P, Aroonlerk N, Suksamrarn A (2002) Xanthones from the Green Fruit Hulls of Garcinia mangostana. J Nat Prod 65:761–763
Iwo MI, Soemardji AA, Hanafi M (2013) Sunscreen activity of [alpha]-mangostin from the pericarps of Garcinia mangostana. J Appl Pharm Sci 3:70
Ha LD, Hansen PE, Vang O, Duus F, Pham HD, Nguyen L-HD (2009) Cytotoxic geranylated xanthones and O-alkylated derivatives of alpha.-mangostin. Chem Pharm Bull 57:830–834
Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvuori R, Hase TA (1982) The structures of garcinones A, B and C: three new xanthones from Garcinia mangostana. Phytochemistry 21:1747–1750
Ampofo SA, Waterman PG (1986) Xanthones from three Garcinia species. Phytochemistry 25:2351–2355
Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvuori R, Haset TA (1980) A xanthone from Garcinia mangostana. Phytochemistry 19:2223–2225
Wu C-H, Huang S-M, Lin J-A, Yen G-C (2011) Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct 2:224–234
Bechtold U, Rabbani N, Mullineaux PM, Thornalley PJ (2009) Quantitative measurement of specific biomarkers for protein oxidation, nitration and glycation in Arabidopsis leaves. Plant J 59:661–671
Mahabusarakam W, Proudfoot J, Taylor W, Croft K (2000) Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic Res 33:643–659
Thong NM, Quang DT, Bui NHT, Dao DQ, Nam PC (2015) Antioxidant properties of xanthones extracted from the pericarp of Garcinia mangostana (Mangosteen): a theoretical study. Chem Phys Lett 625:30–35
Jariyapongskul A, Areebambud C, Suksamrarn S, Mekseepralard C (2015) Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed Res Int 2015:785826
Minami H, Kinoshita M, Fukuyama Y, Kodama M, Yoshizawa T, Sugiura M, Nakagawa K, Tago H (1994) Antioxidant xanthones from Garcinia subelliptica. Phytochemistry 36:501–506
Cahyana AH, Wibowo W, Abdullah I (2015) Prenylation of xanthone extract from Mangosteen (Garcinia mangostana L.) rind by using superbase catalyst of [gamma]-alumina/NaOH/Na and antioxidant activity test. Asian J Chem 27:2228
Ferchichi L, Derbré S, Mahmood K, Touré K, Guilet D, Litaudon M, Awang K, Hadi AHA, Le Ray AM, Richomme P (2012) Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. Phytochemistry 78:98–106
Acknowledgments
This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, the Kingdom of Saudi Arabia, Award Number 12-BIO3087-03. The authors also acknowledge with thanks the Science and Technology Unit, King Abdulaziz University, for the technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdallah, H.M., El-Bassossy, H.M., Mohamed, G.A. et al. Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana . J Nat Med 71, 216–226 (2017). https://doi.org/10.1007/s11418-016-1051-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-016-1051-8